These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32903928)

  • 1. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.
    Masago T; Kobayakawa S; Ohtani Y; Taniguchi K; Naka T; Kuroda N; Takahashi C; Isoyama T; Sejima T
    Int Cancer Conf J; 2020 Oct; 9(4):182-186. PubMed ID: 32903928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.
    Pan X; Quan J; Zhao L; Li W; Wei B; Yang S; Lai Y
    Mol Clin Oncol; 2018 Jan; 8(1):83-85. PubMed ID: 29399348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
    Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
    BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.
    Yang D; Tang W; Liu M; Xie Z; Shi F; Zhao Z; Yang X; Wu T
    Oncol Lett; 2024 Jan; 27(1):29. PubMed ID: 38073770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
    Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
    Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report.
    Zhao J; Dai K; Xie J; Fang C; Chen N; Dai J; Xu D
    Front Pharmacol; 2022; 13():927299. PubMed ID: 36034832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
    Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
    Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
    Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review.
    Xu ZY; Wang JP; Zhang Y; Wu SW; Ma L; Qin YZ; Wang ZP; Chai DM; Tao YS
    Am J Transl Res; 2019; 11(1):327-339. PubMed ID: 30787990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with
    Hu L; Li L; Li A; Tong J
    Open Med (Wars); 2024; 19(1):20240985. PubMed ID: 38953008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis.
    Al-Maghrabi J; Mufti S; Gomaa W
    Pol J Pathol; 2018; 69(4):376-383. PubMed ID: 30786687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.
    Wang Y; Wang Y; Feng M; Lian X; Lei Y; Zhou H
    J Int Med Res; 2020 Oct; 48(10):300060520942095. PubMed ID: 33026261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
    Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
    Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic features.
    Zhan HQ; Chen H; Wang CF; Zhu XZ
    Hum Pathol; 2015 Mar; 46(3):476-81. PubMed ID: 25582502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary bypass-assisted surgery for the treatment of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a tumor thrombus within the inferior vena cava: A case report.
    Zhu G; Qiu X; Chen X; Liu G; Zhang G; Gan W; Guo H
    Oncol Lett; 2015 Dec; 10(6):3532-3534. PubMed ID: 26788164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.